StockNews.com Begins Coverage on Senseonics (NYSE:SENS)

StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS) in a report issued on Thursday. The firm issued a sell rating on the stock.

Senseonics Stock Performance

Shares of NYSE:SENS opened at $0.47 on Thursday. The company has a quick ratio of 3.70, a current ratio of 3.96 and a debt-to-equity ratio of 1.79. Senseonics has a 52 week low of $0.37 and a 52 week high of $1.05. The company has a 50 day moving average price of $0.43 and a two-hundred day moving average price of $0.51.

Senseonics (NYSE:SENS) last issued its quarterly earnings data on Monday, May 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). Senseonics had a negative return on equity of 202.32% and a negative net margin of 346.38%. The business had revenue of $5.05 million during the quarter, compared to analyst estimates of $4.76 million. As a group, analysts forecast that Senseonics will post -0.12 EPS for the current year.

Institutional Investors Weigh In On Senseonics

Several institutional investors have recently added to or reduced their stakes in SENS. Virtu Financial LLC acquired a new stake in shares of Senseonics in the 1st quarter valued at about $162,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Senseonics by 16.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after buying an additional 51,000 shares in the last quarter. Vanguard Group Inc. raised its position in Senseonics by 0.7% in the 1st quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after buying an additional 155,715 shares during the last quarter. State Board of Administration of Florida Retirement System bought a new stake in Senseonics in the 1st quarter valued at approximately $91,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in Senseonics by 30.2% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock worth $483,000 after acquiring an additional 211,128 shares during the last quarter. 12.36% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.